Close
Smartlab Europe
Inizio Ignite

Press Releases

Envirotainer launches the Releye RLP – simpler than passive, even better than active

Envirotainer, the global market leader in secure cold chain solutions for air transportation of pharmaceuticals, launched their latest innovation, the Releye® RLP, a temperature-controlled air freight container with a revolutionary new footprint, unsurpassed autonomy, fully integrated live monitoring, and...

21st Edition Strategic Project & Portfolio Management for Pharma

The economic turmoil has taken a toll on pharma and biotech companies who have been confronted by stringent regulations and budget cuts in R&D. Furthermore, Covid-19 and the related crisis has made the need for better prioritization and faster...

Pfizer and BioNTech Receive First U.S. Authorization for Emergency Use of COVID-19 Vaccine in Adolescents

Pfizer Inc. and BioNTech SE announced today that the U.S. FDA has expanded the Emergency Use Authorization (EUA) for their COVID-19 vaccine to include individuals 12 to 15 years of age. This is the first COVID-19 vaccine authorized in...

GSK and Vir Biotechnology Announce the Start of the EMA Rolling Review of VIR-7831 for the Early Treatment of COVID-19

GlaxoSmithKline plc and Vir Biotechnology, Inc. announced that the EMA has started a rolling review of data on sotrovimab, an investigational dual-action SARS-CoV-2 monoclonal antibody, for the treatment of adults and adolescents (aged 12 years and over and weighing...

Vectura and Inspira Pharmaceuticals Sign Agreement to Develop Potential Inhaled Treatment for COVID-19

Vectura Group plc, an industry leading inhalation CDMO, and Inspira Pharmaceuticals Limited, a new UK-based company focused on developing therapies for respiratory and infectious diseases, announced an agreement to develop an inhaled formulation of Inspira’s lead drug candidate for...

Cryoport and LabConnectPartner to Provide Support for Innovative Triumvira Cell and Gene Therapy Clinical Trial

LabConnect, Inc. and Cryoport, Inc. announced a partnership to provide comprehensive logistics support for an upcoming Phase I/II clinical trial sponsored by Triumvira Immunologics Inc., a privately held biopharmaceutical company developing a novel platform for engineering T cells to...

Moderna Announces Emergency Use Listing Granted by the World Health Organization for its COVID-19 Vaccine

Moderna, Inc. , a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the World Health Organization (WHO) has issued Emergency Use Listing (EUL) for its COVID-19 vaccine to prevent COVID-19 in individuals 18 years of age...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »